News

Everton fan and broadcaster David Downie spoke to BBC Radio Merseyside about Dominic Calvert-Lewin's departure: "Right now we ...
5 Live listeners have their say with Nicky Campbell.
Aubrey O’Day has shared her reaction to the results of Sean “Diddy” Combs ‘ trial, which concluded Wednesday (July 2) with a ...
BBC Breakfast and 'The Rest Is Money' presenter shared her views on the teary Chancellor.
A group of faith leaders, community advocates, and activists continues to call on the Monroe County District Attorney’s ...
Results from the Phase III BASIS trial show that once-weekly subcutaneous Hympavzi reduced annualized bleeding rates by 93% ...
ICE raids are disrupting worksites across the country, particularly construction sites, as President Trump’s mass deportation ...
The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with ...
Approved eight months ago for a certain class of patients with both hemophilia A or B, Pfizer’s Hympavzi has now shown its ...
Pfizer said a late-stage study of its Hympavzi hemophilia drug met its key goals in patients with the blood-clotting disorder who have inhibitors that can render some treatments ineffective.
On June 26, Pfizer announced positive topline results from its Phase 3 BASIS study evaluating HYMPAVZI (marstacimab) for ...
Responses cited increasing workloads, shrinking autonomy, mounting interference from hospital administrators and insurance ...